#LI-Onsite
The Opportunity
insitro is changing the way drugs are discovered and developed for patients by using AI/ML to address bottlenecks throughout the drug discovery and development process. Our models are derived from a combination of external human cohort data and high-quality in vitro data generated in-house. To enable and implement this vision, we're building a unique, high-efficiency research and development engine that incorporates a range of modern technologies - both experimental and computational - and deploys them robustly and at scale to generate a pipeline of differentiated therapeutics.
We are seeking an experienced patent attorney to lead our intellectual property efforts in developing and executing a robust intellectual property strategy, addressed to advancing business goals at the intersection of computation, biology and chemistry. Reporting to the Chief Legal Officer, you will have a broad scope of responsibilities related to the development, management and deployment of intellectual property assets for business value, as well as managing third-party intellectual property risk, licensing and freedom to operate matters. Our unique scientific strategy requires a similarly unique approach to intellectual property, spanning cutting edge capabilities in AI/ML, cell biology, chemistry, and more; novel approaches that often bring together ideas from these diverse disciplines; and therapeutic intervention patents that include both molecules and new types of biomarkers. In this role, you will need a deep understanding of these diverse disciplines as well as the ways in which they can synergize to create disproportionate value. Your role will require you to craft new IP strategies for cross-disciplinary inventions to provide a much stronger competitive moat for our work at insitro.
The role requires exemplary leadership, collaboration, communication, and influencing skills as well as a curious mind and desire to learn. The role also requires a business-oriented and outcome-driven approach. The role will be based in South San Francisco, with a hybrid approach of three days per week in the office. This is an excellent opportunity for a seasoned IP attorney who is passionate about using their skills at the intersection of legal matters and company building to advance therapeutic discovery and help make a difference to patients.
Responsibilities
Your responsibilities will include, but not be limited to:
About You
Nice to Have
Our target starting salary for successful US-based applicants for this role is $275,000.00 - $345,000.00. To determine starting pay, we consider multiple job-related factors including a candidate's skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.
This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees:
insitro is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams–grounded in a wide range of expertise and life experiences–and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.
About insitro insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience, oncology and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.